Notification of Results

RNS Number : 4123G

Futura Medical PLC

01 February 2010

 



For immediate release

1 February 2010

 

Futura Medical plc

("Futura" or "the Company")

 Notification of Preliminary Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that it will issue its preliminary results for the year ended 31 December 2009 on Tuesday 2 March 2010.

A meeting for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Stasa Filiplic / Jennie Spivey	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NORUAUKRRVAAOAR